Factor xi deficiency
Factor XI Deficiency
Factor XI deficiency (pronounced: fak-tor e-le-ven de-fi-shen-see), also known as Hemophilia C, is a rare genetic disorder that affects the body's ability to control blood clotting. It is caused by a deficiency in a protein in the blood known as Factor XI.
Etymology
The term "Factor XI deficiency" is derived from the name of the protein that is deficient in this condition, Factor XI. The term "Hemophilia C" is used because this condition is a type of hemophilia, a group of genetic disorders that affect the body's ability to control blood clotting.
Symptoms
People with Factor XI deficiency may experience prolonged bleeding after surgery or injury, and in severe cases, spontaneous bleeding. Women with this condition may have heavy menstrual bleeding and may be at increased risk for bleeding complications during childbirth.
Diagnosis
Factor XI deficiency is diagnosed through a blood test that measures the level of Factor XI in the blood. A low level of Factor XI is indicative of this condition.
Treatment
Treatment for Factor XI deficiency typically involves replacing the missing Factor XI through infusion therapy. This can be done using a product derived from donated human blood that contains Factor XI, or a recombinant product that is made in a laboratory.
Related Terms
- Hemophilia: A group of genetic disorders that affect the body's ability to control blood clotting.
- Blood clotting: The process by which the body stops bleeding.
- Infusion therapy: A treatment method that involves delivering medication directly into the bloodstream.
External links
- Medical encyclopedia article on Factor xi deficiency
- Wikipedia's article - Factor xi deficiency
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski